Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Marcus

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
Behavioural Brain Research|March 8, 2011
Hcrtr1 and 2 signaling differentially regulates depression-like behaviorsMichael M Scott, Jacob N Marcus, Ami Pettersen, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studiesPhilip G Janicak, Ira D Glick, Stephen R Marder, et al.
The American Journal of Pathology|December 1, 1994
Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behaviorS S Bacus, C R Zelnick, D M Chin, et al.
Archives of Biochemistry and Biophysics|February 1, 1994
Erp61 is GRP58, a stress-inducible luminal endoplasmic reticulum protein, but is devoid of phosphatidylinositide-specific phospholipase C activityR A Mazzarella, N Marcus, S M Haugejorden, et al.
Journal of Lipid Research|April 30, 2022
Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomesNanyan Rena Zhang, Nathan G Hatcher, Kim Ekroos, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studiesMaurizio Fava, Stephen R Wisniewski, Michael E Thase, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2011
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label studyRonald N Marcus, Randall Owen, George Manos, et al.
Schizophrenia Research|February 18, 2006
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)Rajiv Tandon, Ronald N Marcus, Elyse G Stock, et al.
Circulation|March 15, 2006
Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal interventionKaarin Mäkikallio, Doff B McElhinney, Jami C Levine, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled studyRonald N Marcus, Robert D McQuade, William H Carson, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
Behavioural Brain Research|March 8, 2011
Hcrtr1 and 2 signaling differentially regulates depression-like behaviorsMichael M Scott, Jacob N Marcus, Ami Pettersen, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studiesPhilip G Janicak, Ira D Glick, Stephen R Marder, et al.
The American Journal of Pathology|December 1, 1994
Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behaviorS S Bacus, C R Zelnick, D M Chin, et al.
Archives of Biochemistry and Biophysics|February 1, 1994
Erp61 is GRP58, a stress-inducible luminal endoplasmic reticulum protein, but is devoid of phosphatidylinositide-specific phospholipase C activityR A Mazzarella, N Marcus, S M Haugejorden, et al.
Journal of Lipid Research|April 30, 2022
Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomesNanyan Rena Zhang, Nathan G Hatcher, Kim Ekroos, et al.
Journal of Clinical Psychopharmacology|July 14, 2009
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studiesMaurizio Fava, Stephen R Wisniewski, Michael E Thase, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2011
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label studyRonald N Marcus, Randall Owen, George Manos, et al.
Schizophrenia Research|February 18, 2006
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)Rajiv Tandon, Ronald N Marcus, Elyse G Stock, et al.
Circulation|March 15, 2006
Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal interventionKaarin Mäkikallio, Doff B McElhinney, Jami C Levine, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled studyRonald N Marcus, Robert D McQuade, William H Carson, et al.
Pageof 23